The story of Cole highlights a growing concern regarding the practices of Pharmacy Benefit Managers (PBMs) and their influence on the healthcare system. PBMs are intermediaries that manage prescription drug benefits on behalf of health insurers, employers, and other organizations. While they were initially created to reduce costs, there are increasing allegations that their business tactics can adversely affect patients and lead to tragic outcomes, as seen in Cole’s case. Many families are unaware of how PBMs operate and the potential harm they can cause. These managers negotiate pricing with drug manufacturers and pharmacies, but their methods can lead to higher out-of-pocket expenses for patients who desperately need medications. The cost of essential drugs should not be dictated by corporate greed. Understanding this issue is vital for consumers and healthcare advocates. Efforts for #PBMReform are accelerating, with demand for transparency in drug pricing and regulation of PBM practices growing louder. Advocates argue that it's crucial for policy changes to protect consumers, ensuring patients receive necessary medications without the burden of excessive costs dictated by PBMs. As more individuals share their experiences, the call for justice grows stronger. Connecting with organizations and campaigns that focus on PBM accountability can amplify these voices. It's essential to advocate for systemic changes that prioritize patient welfare over corporate profits. By standing together and sharing stories, we can raise awareness and initiate meaningful reforms in the pharmaceutical industry.